186 related articles for article (PubMed ID: 30191107)
1. Research advances in Apert syndrome.
Das S; Munshi A
J Oral Biol Craniofac Res; 2018; 8(3):194-199. PubMed ID: 30191107
[TBL] [Abstract][Full Text] [Related]
2. Morphological comparison of the craniofacial phenotypes of mouse models expressing the Apert FGFR2 S252W mutation in neural crest- or mesoderm-derived tissues.
Heuzé Y; Singh N; Basilico C; Jabs EW; Holmes G; Richtsmeier JT
Bone; 2014 Jun; 63():101-9. PubMed ID: 24632501
[TBL] [Abstract][Full Text] [Related]
3. Midface and upper airway dysgenesis in FGFR2-related craniosynostosis involves multiple tissue-specific and cell cycle effects.
Holmes G; O'Rourke C; Motch Perrine SM; Lu N; van Bakel H; Richtsmeier JT; Jabs EW
Development; 2018 Oct; 145(19):. PubMed ID: 30228104
[TBL] [Abstract][Full Text] [Related]
4. Genetic Syndromes Associated with Craniosynostosis.
Ko JM
J Korean Neurosurg Soc; 2016 May; 59(3):187-91. PubMed ID: 27226847
[TBL] [Abstract][Full Text] [Related]
5. Closing the Gap: Genetic and Genomic Continuum from Syndromic to Nonsyndromic Craniosynostoses.
Heuzé Y; Holmes G; Peter I; Richtsmeier JT; Jabs EW
Curr Genet Med Rep; 2014 Sep; 2(3):135-145. PubMed ID: 26146596
[TBL] [Abstract][Full Text] [Related]
6. A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis.
Yin L; Du X; Li C; Xu X; Chen Z; Su N; Zhao L; Qi H; Li F; Xue J; Yang J; Jin M; Deng C; Chen L
Bone; 2008 Apr; 42(4):631-43. PubMed ID: 18242159
[TBL] [Abstract][Full Text] [Related]
7. Insights and future directions of potential genetic therapy for Apert syndrome: A systematic review.
Al-Namnam NM; Jayash SN; Hariri F; Rahman ZAA; Alshawsh MA
Gene Ther; 2021 Nov; 28(10-11):620-633. PubMed ID: 33619359
[TBL] [Abstract][Full Text] [Related]
8. Negative autoregulation of fibroblast growth factor receptor 2 expression characterizing cranial development in cases of Apert (P253R mutation) and Pfeiffer (C278F mutation) syndromes and suggesting a basis for differences in their cranial phenotypes.
Britto JA; Moore RL; Evans RD; Hayward RD; Jones BM
J Neurosurg; 2001 Oct; 95(4):660-73. PubMed ID: 11596961
[TBL] [Abstract][Full Text] [Related]
9. Two patients with Apert syndrome with different mutations: the importance of early diagnosis.
Işık E; Atik T; Onay H; Özkınay F
Turk Pediatri Ars; 2017 Dec; 52(4):231-235. PubMed ID: 29483804
[TBL] [Abstract][Full Text] [Related]
10. Craniosynostosis genetics: The mystery unfolds.
Panigrahi I
Indian J Hum Genet; 2011 May; 17(2):48-53. PubMed ID: 22090712
[TBL] [Abstract][Full Text] [Related]
11. Dura in the pathogenesis of syndromic craniosynostosis: fibroblast growth factor receptor 2 mutations in dural cells promote osteogenic proliferation and differentiation of osteoblasts.
Ang BU; Spivak RM; Nah HD; Kirschner RE
J Craniofac Surg; 2010 Mar; 21(2):462-7. PubMed ID: 20489451
[TBL] [Abstract][Full Text] [Related]
12. Deformed Skull Morphology Is Caused by the Combined Effects of the Maldevelopment of Calvarias, Cranial Base and Brain in FGFR2-P253R Mice Mimicking Human Apert Syndrome.
Luo F; Xie Y; Xu W; Huang J; Zhou S; Wang Z; Luo X; Liu M; Chen L; Du X
Int J Biol Sci; 2017; 13(1):32-45. PubMed ID: 28123344
[TBL] [Abstract][Full Text] [Related]
13. Apert syndrome with S252W FGFR2 mutation and characterization using Phenomizer: An Indian case report.
Kunwar F; Tewari S; Bakshi SR
J Oral Biol Craniofac Res; 2017; 7(1):67-71. PubMed ID: 28316926
[TBL] [Abstract][Full Text] [Related]
14. FGFR2 mutation in a patient with Apert syndrome associated with humeroradial synostosis.
Kanauchi Y; Muragaki Y; Ogino T; Takahara M; Tsuchida H; Ishigaki D
Congenit Anom (Kyoto); 2003 Dec; 43(4):302-5. PubMed ID: 15041782
[TBL] [Abstract][Full Text] [Related]
15. Increased EFG- and PDGFalpha-receptor signaling by mutant FGF-receptor 2 contributes to osteoblast dysfunction in Apert craniosynostosis.
Miraoui H; Ringe J; Häupl T; Marie PJ
Hum Mol Genet; 2010 May; 19(9):1678-89. PubMed ID: 20124286
[TBL] [Abstract][Full Text] [Related]
16. Apert syndrome without craniosynostosis.
de Ângelis Ramos D; Matushita H; Cardeal DD; Nascimento CNG; Teixeira MJ
Childs Nerv Syst; 2019 Mar; 35(3):565-567. PubMed ID: 30643948
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of a novel FGFR2 mutation, E731K, in craniosynostosis.
Park J; Park OJ; Yoon WJ; Kim HJ; Choi KY; Cho TJ; Ryoo HM
J Cell Biochem; 2012 Feb; 113(2):457-64. PubMed ID: 21928350
[TBL] [Abstract][Full Text] [Related]
18. Identical Twins Discordant for Metopic Craniosynostosis: Evidence of Epigenetic Influences.
Magge SN; Snyder K; Sajja A; DeFreitas TA; Hofherr SE; Broth RE; Keating RF; Rogers GF
J Craniofac Surg; 2017 Jan; 28(1):14-16. PubMed ID: 28060197
[TBL] [Abstract][Full Text] [Related]
19. Dermal fibroblast transcriptome indicates contribution of WNT signaling pathways in the pathogenesis of Apert syndrome.
Çetinkaya A; Taşkıran E; Soyer T; Şimşek-Kiper PÖ; Utine GE; Tunçbilek G; Boduroğlu K; Alikaşifoğlu M
Turk J Pediatr; 2017; 59(6):619-624. PubMed ID: 30035392
[TBL] [Abstract][Full Text] [Related]
20. Mandibular dysmorphology due to abnormal embryonic osteogenesis in FGFR2-related craniosynostosis mice.
Motch Perrine SM; Wu M; Stephens NB; Kriti D; van Bakel H; Jabs EW; Richtsmeier JT
Dis Model Mech; 2019 May; 12(5):. PubMed ID: 31064775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
